Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩24,350, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Personal Products industry in South Korea. Negligible returns to shareholders over past three years. Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩24,650, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total loss to shareholders of 7.9% over the past three years. Announcement • Apr 24
AMOREPACIFIC Holdings Corp. to Report Q1, 2026 Results on Apr 29, 2026 AMOREPACIFIC Holdings Corp. announced that they will report Q1, 2026 results on Apr 29, 2026 Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₩25,500, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 33% over the past three years. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₩35,000, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 16% over the past three years. Declared Dividend • Feb 09
Dividend increased to ₩400 Dividend of ₩400 is 21% higher than last year. Ex-date: 30th March 2026 Payment date: 1st January 1970 Dividend yield will be 1.3%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (37% earnings payout ratio) and cash flows (6% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 98% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Price Target Changed • Dec 13
Price target increased by 15% to ₩36,333 Up from ₩31,500, the current price target is an average from 3 analysts. New target price is 33% above last closing price of ₩27,400. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₩2,879 for next year compared to ₩2,567 last year. Major Estimate Revision • Nov 08
Consensus EPS estimates increase by 20% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from ₩4.63b to ₩4.72b. EPS estimate increased from ₩2,279 to ₩2,741 per share. Net income forecast to grow 303% next year vs 72% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩31,250 unchanged from last update. Share price rose 4.7% to ₩26,600 over the past week. Major Estimate Revision • Oct 11
Consensus EPS estimates increase by 15%, revenue downgraded The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from ₩4.75b to ₩4.63b. EPS estimate rose from ₩2,441 to ₩2,817. Net income forecast to grow 267% next year vs 81% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩31,250 unchanged from last update. Share price fell 2.1% to ₩25,950 over the past week. New Risk • Aug 24
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.4% Last year net profit margin: 6.9% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (1.4% net profit margin). Major Estimate Revision • May 20
Consensus revenue estimates decrease by 10% The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from ₩5.21b to ₩4.67b. EPS estimate reaffirmed at ₩3,501. Net income forecast to grow 36% next year vs 34% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩32,500 unchanged from last update. Share price was steady at ₩22,900 over the past week. Announcement • Apr 24
AMOREPACIFIC Group to Report Q1, 2025 Final Results on Apr 30, 2025 AMOREPACIFIC Group announced that they will report Q1, 2025 final results on Apr 30, 2025 Reported Earnings • Mar 21
Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2024 results: EPS: ₩2,782 (up from ₩1,296 in FY 2023). Revenue: ₩4.26t (up 5.9% from FY 2023). Net income: ₩252.0b (up 111% from FY 2023). Profit margin: 5.9% (up from 3.0% in FY 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 3.2%. Earnings per share (EPS) exceeded analyst estimates by 1.2%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. Upcoming Dividend • Mar 20
Upcoming dividend of ₩330 per share Eligible shareholders must have bought the stock before 27 March 2025. Payment date: 14 April 2025. Payout ratio is a comfortable 7.8% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of South Korean dividend payers (3.9%). In line with average of industry peers (1.1%). Announcement • Feb 07
AMOREPACIFIC Group, Annual General Meeting, Mar 25, 2025 AMOREPACIFIC Group, Annual General Meeting, Mar 25, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 100, hangang-daero, yongsan-gu, seoul South Korea Price Target Changed • Dec 28
Price target decreased by 15% to ₩35,167 Down from ₩41,333, the current price target is an average from 6 analysts. New target price is 67% above last closing price of ₩21,000. Stock is down 28% over the past year. The company is forecast to post earnings per share of ₩2,749 for next year compared to ₩1,196 last year. New Risk • Dec 27
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 2.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.6% per year for the foreseeable future. Minor Risk Large one-off items impacting financial results. Reported Earnings • Nov 20
Third quarter 2024 earnings released: EPS: ₩286 (vs ₩270 in 3Q 2023) Third quarter 2024 results: EPS: ₩286 (up from ₩270 in 3Q 2023). Revenue: ₩1.07t (up 11% from 3Q 2023). Net income: ₩26.4b (up 5.4% from 3Q 2023). Profit margin: 2.5% (in line with 3Q 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings. Price Target Changed • Oct 14
Price target decreased by 7.4% to ₩41,500 Down from ₩44,833, the current price target is an average from 6 analysts. New target price is 73% above last closing price of ₩24,000. Stock is down 9.4% over the past year. The company is forecast to post earnings per share of ₩2,066 for next year compared to ₩1,196 last year. Valuation Update With 7 Day Price Move • Aug 07
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₩24,200, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 57% over the past three years. Price Target Changed • May 11
Price target increased by 8.3% to ₩39,167 Up from ₩36,167, the current price target is an average from 6 analysts. New target price is 12% above last closing price of ₩35,050. Stock is up 10% over the past year. The company is forecast to post earnings per share of ₩1,963 for next year compared to ₩1,444 last year. Major Estimate Revision • May 08
Consensus EPS estimates increase by 18% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from ₩1,812 to ₩2,145. Revenue forecast steady at ₩4.76b. Net income forecast to grow 51% next year vs 86% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩36,167 to ₩37,667. Share price fell 3.1% to ₩32,600 over the past week. Reported Earnings • Mar 12
Full year 2023 earnings released: EPS: ₩1,296 (vs ₩657 in FY 2022) Full year 2023 results: EPS: ₩1,296 (up from ₩657 in FY 2022). Revenue: ₩4.02t (down 11% from FY 2022). Net income: ₩119.3b (up 92% from FY 2022). Profit margin: 3.0% (up from 1.4% in FY 2022). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Feb 07
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩29,450, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 12x in the Personal Products industry in South Korea. Total loss to shareholders of 52% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩52,865 per share. Upcoming Dividend • Dec 20
Upcoming dividend of ₩205 per share at 0.7% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 15 April 2024. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.2%). Valuation Update With 7 Day Price Move • Nov 06
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩31,300, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total loss to shareholders of 32% over the past three years. Reported Earnings • Aug 20
Second quarter 2023 earnings released: EPS: ₩242 (vs ₩6.00 loss in 2Q 2022) Second quarter 2023 results: EPS: ₩242 (up from ₩6.00 loss in 2Q 2022). Revenue: ₩1.03t (flat on 2Q 2022). Net income: ₩22.5b (up ₩22.6b from 2Q 2022). Profit margin: 2.2% (up from 0% in 2Q 2022). Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 8.8% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 17% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Aug 10
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩34,800, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total loss to shareholders of 40% over the past three years. Major Estimate Revision • Jul 28
Consensus EPS estimates fall by 14% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from ₩1,231 to ₩1,057 per share. Revenue forecast steady at ₩4.44b. Net income forecast to grow 104% next year vs 149% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩33,800 to ₩32,400. Share price was steady at ₩27,100 over the past week. Price Target Changed • Jul 07
Price target decreased by 9.2% to ₩35,400 Down from ₩39,000, the current price target is an average from 5 analysts. New target price is 41% above last closing price of ₩25,150. Stock is down 33% over the past year. The company is forecast to post earnings per share of ₩1,275 for next year compared to ₩606 last year. Major Estimate Revision • Mar 30
Consensus EPS estimates fall by 12% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩4.84b to ₩4.74b. EPS estimate also fell from ₩1,599 per share to ₩1,415 per share. Net income forecast to grow 118% next year vs 127% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩39,740 unchanged from last update. Share price was steady at ₩38,300 over the past week. Reported Earnings • Mar 12
Full year 2022 earnings released: EPS: ₩657 (vs ₩1,989 in FY 2021) Full year 2022 results: EPS: ₩657 (down from ₩1,989 in FY 2021). Revenue: ₩4.49t (down 16% from FY 2021). Net income: ₩62.2b (down 65% from FY 2021). Profit margin: 1.4% (down from 3.4% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 11% per year. Major Estimate Revision • Jan 16
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate increased from ₩743 to ₩977. Revenue forecast unchanged at ₩4.52b. Net income forecast to grow 508% next year vs 124% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩38,800 unchanged from last update. Share price was steady at ₩38,300 over the past week. Price Target Changed • Jan 14
Price target increased to ₩38,800 Up from ₩35,000, the current price target is an average from 5 analysts. New target price is 5.3% above last closing price of ₩36,850. Stock is down 11% over the past year. The company is forecast to post earnings per share of ₩743 for next year compared to ₩2,024 last year. Upcoming Dividend • Dec 21
Upcoming dividend of ₩450 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 1.4%. Lower than top quartile of South Korean dividend payers (3.3%). In line with average of industry peers (1.3%). Major Estimate Revision • Nov 30
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate increased from ₩649 to ₩743. Revenue forecast steady at ₩4.46b. Net income forecast to grow 490% next year vs 59% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩44,667 to ₩35,000. Share price rose 6.6% to ₩31,650 over the past week. Price Target Changed • Nov 25
Price target decreased to ₩45,400 Down from ₩49,667, the current price target is an average from 5 analysts. New target price is 47% above last closing price of ₩30,800. Stock is down 30% over the past year. The company is forecast to post earnings per share of ₩1,228 for next year compared to ₩2,024 last year. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). Non-Executive Director Jung-il Choi was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Price Target Changed • Sep 29
Price target decreased to ₩49,667 Down from ₩53,667, the current price target is an average from 6 analysts. New target price is 77% above last closing price of ₩28,050. Stock is down 43% over the past year. The company is forecast to post earnings per share of ₩1,228 for next year compared to ₩2,024 last year. Major Estimate Revision • Sep 20
Consensus EPS estimates fall by 33% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩4.90b to ₩4.84b. EPS estimate also fell from ₩1,743 per share to ₩1,162 per share. Net income forecast to grow 458% next year vs 45% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩53,667. Share price fell 2.6% to ₩33,250 over the past week. Price Target Changed • Apr 29
Price target increased to ₩53,875 Up from ₩49,833, the current price target is an average from 4 analysts. New target price is 7.7% above last closing price of ₩50,000. Stock is down 32% over the past year. The company is forecast to post earnings per share of ₩1,348 for next year compared to ₩2,178 last year. Major Estimate Revision • Apr 29
Consensus revenue estimates fall by 11% The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from ₩5.63b to ₩5.03b. EPS estimate fell from ₩2,019 to ₩1,348 per share. Net income forecast to shrink 28% next year vs 22% growth forecast for Personal Products industry in South Korea . Consensus price target of ₩49,375 unchanged from last update. Share price rose 6.6% to ₩50,000 over the past week. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). Non-Executive Director Jung-il Choi was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Major Estimate Revision • Mar 29
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate increased from ₩1,943 to ₩2,262. Revenue forecast steady at ₩5.62b. Net income forecast to grow 14% next year vs 37% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩49,833 to ₩47,167. Share price was steady at ₩44,150 over the past week. Price Target Changed • Jan 18
Price target decreased to ₩63,583 Down from ₩70,300, the current price target is an average from 6 analysts. New target price is 55% above last closing price of ₩40,900. Stock is down 33% over the past year. The company is forecast to post earnings per share of ₩2,505 for next year compared to ₩120 last year. Upcoming Dividend • Dec 22
Upcoming dividend of ₩230 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 18 April 2022. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (0.8%). Price Target Changed • Nov 25
Price target decreased to ₩70,400 Down from ₩76,311, the current price target is an average from 8 analysts. New target price is 54% above last closing price of ₩45,600. Stock is down 13% over the past year. The company is forecast to post earnings per share of ₩2,686 for next year compared to ₩120 last year. Price Target Changed • Apr 30
Price target increased to ₩83,225 Up from ₩72,050, the current price target is an average from 8 analysts. New target price is 13% above last closing price of ₩73,500. Stock is up 27% over the past year. Major Estimate Revision • Apr 29
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 EPS estimate increased from ₩1,511 to ₩1,703. Revenue forecast steady at ₩5.50b. Net income forecast to grow 1,239% next year vs 46% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩69,009 to ₩72,050. Share price rose 6.1% to ₩72,700 over the past week. Price Target Changed • Apr 28
Price target increased to ₩73,800 Up from ₩68,840, the current price target is an average from 7 analysts. New target price is approximately in line with last closing price of ₩72,700. Stock is up 25% over the past year. Reported Earnings • Mar 14
Full year 2020 earnings released: EPS ₩74.00 (vs ₩1,444 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩4.93t (down 22% from FY 2019). Net income: ₩10.4b (down 92% from FY 2019). Profit margin: 0.2% (down from 2.1% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has only fallen by 23% per year, which means it has not declined as severely as earnings. Price Target Changed • Feb 05
Price target raised to ₩68,240 Up from ₩61,882, the current price target is an average from 9 analysts. The new target price is 8.8% above the current share price of ₩62,700. As of last close, the stock is down 9.5% over the past year. Major Estimate Revision • Feb 04
Analysts lower EPS estimates to ₩1,540 The 2021 consensus revenue estimate was lowered from ₩5.70b to ₩5.63b. Earning per share (EPS) estimate was also lowered from ₩1,761 to ₩1,540 for the same period. Net income is expected to grow by 3,499% next year compared to 49% growth forecast for the Personal Products industry in South Korea. The consensus price target increased from ₩61,882 to ₩63,940. Share price stayed mostly flat at ₩61,100 over the past week. Is New 90 Day High Low • Jan 13
New 90-day high: ₩60,600 The company is up 25% from its price of ₩48,300 on 15 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩106,918 per share. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩300 Per Share Will be paid on the 17th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.6% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (0.6%). Is New 90 Day High Low • Dec 09
New 90-day high: ₩57,200 The company is up 14% from its price of ₩50,000 on 10 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩101,766 per share. Major Estimate Revision • Oct 29
Analysts update estimates The 2020 consensus earning per share (EPS) estimate increased from ₩766 to ₩892. Revenue estimate for the same period was approximately flat at ₩5.03b. Net income is expected to grow by 163% next year compared to 73% growth forecast for the Personal Products industry in South Korea. The consensus price target was lowered from ₩71,364 to ₩59,700. Share price is down by 5.3% to ₩45,450 over the past week. Price Target Changed • Oct 29
Price target lowered to ₩59,700 Down from ₩71,364, the current price target is an average from 11 analysts. The new target price is 31% above the current share price of ₩45,450. As of last close, the stock is down 46% over the past year. Is New 90 Day High Low • Oct 26
New 90-day low: ₩46,800 The company is down 12% from its price of ₩53,100 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩102,245 per share. 
